A net clinical benefit analysis of warfarin and aspirin on stroke in patients with atrial fibrillation: a nested case–control study
<p>Abstract</p> <p>Background</p> <p>As the management of patients treated with anticoagulants and antiplatelet drugs entails balancing coagulation levels, we evaluated the net clinical benefit of warfarin and aspirin on stroke in a large cohort of patients with atrial...
Main Authors: | Azoulay Laurent, Dell’Aniello Sophie, Simon Teresa A, Langleben David, Renoux Christel, Suissa Samy |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-06-01
|
Series: | BMC Cardiovascular Disorders |
Subjects: | |
Online Access: | http://www.biomedcentral.com/1471-2261/12/49 |
Similar Items
-
Antithrombotic Therapy According to the Guidelines Issued by the Japanese Circulation Society in Patients with Nonvalvular Paroxysmal Atrial Fibrillation without Thromboembolic Risk Factors
by: Mahito Ozawa, MD, et al.
Published: (2009-01-01) -
The Anticoagulation in Patients with Atrial Fibrillation: Rivaroxaban and Warfarin
by: I. Yu. Koroleva, et al.
Published: (2016-11-01) -
Clinical characteristics and antithrombotic status in 621 very elderly hospitalized patients with atrial fibrillation
by: Wen Liu, et al.
Published: (2018-01-01) -
The Prevalence and Risks of Inappropriate Combination of Aspirin and Warfarin in Clinical Practice: Results From WARFARIN-TR Study
by: Salih Kılıç, et al.
Published: (2019-01-01) -
The use of warfarin in veterans with atrial fibrillation
by: Rosenbeck Karen, et al.
Published: (2004-10-01)